Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer—an international, multicentre, real-world analysis by S. Banks, W. Hong, K. Degeling, J. Shapiro, B. Thomson, H.S. Ko, S. Ananda, A. Jalali, Y.H. To, B. Loveday, S.-A. McLachlan, B. Knowles, A. Fox, M. Michael, R. Wong, M. Burge, K. Clarke, S. Pattison, M. Nikfarjam, R. Zielinski, F. Day, C.E. Chee, A. Nagrial, M. IJzerman, P. Gibbs, B. Lee

Get full text